These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
59 related articles for article (PubMed ID: 21702397)
1. Synthetic Pot: Not Your Grandfather's Marijuana. Ford BM; Tai S; Fantegrossi WE; Prather PL Trends Pharmacol Sci; 2017 Mar; 38(3):257-276. PubMed ID: 28162792 [TBL] [Abstract][Full Text] [Related]
2. Substance-Induced Psychoses: An Updated Literature Review. Fiorentini A; Cantù F; Crisanti C; Cereda G; Oldani L; Brambilla P Front Psychiatry; 2021; 12():694863. PubMed ID: 35002789 [No Abstract] [Full Text] [Related]
3. Chronic cannabinoid exposure produces tolerance to the dopamine releasing effects of WIN 55,212-2 and heroin in adult male rats. Gomez DM; Everett TJ; Hamilton LR; Ranganath A; Cheer JF; Oleson EB Neuropharmacology; 2021 Jan; 182():108374. PubMed ID: 33115642 [TBL] [Abstract][Full Text] [Related]
4. An Investigation of the Nennicioglu Y; Kaya H; Eraybar S; Atmaca S; Gorukmez O; Armagan E Balkan J Med Genet; 2020 Jun; 23(1):63-68. PubMed ID: 32953411 [TBL] [Abstract][Full Text] [Related]
5. Designer drugs: mechanism of action and adverse effects. Luethi D; Liechti ME Arch Toxicol; 2020 Apr; 94(4):1085-1133. PubMed ID: 32249347 [TBL] [Abstract][Full Text] [Related]
6. The Bridge Between Classical and "Synthetic"/Chemical Psychoses: Towards a Clinical, Psychopathological, and Therapeutic Perspective. Orsolini L; Chiappini S; Papanti D; De Berardis D; Corkery JM; Schifano F Front Psychiatry; 2019; 10():851. PubMed ID: 31849723 [TBL] [Abstract][Full Text] [Related]
7. Δ9-THC Disrupts Gamma (γ)-Band Neural Oscillations in Humans. Cortes-Briones J; Skosnik PD; Mathalon D; Cahill J; Pittman B; Williams A; Sewell RA; Ranganathan M; Roach B; Ford J; D'Souza DC Neuropsychopharmacology; 2015 Aug; 40(9):2124-34. PubMed ID: 25709097 [TBL] [Abstract][Full Text] [Related]
8. Synthetic cannabinoids: epidemiology, pharmacodynamics, and clinical implications. Castaneto MS; Gorelick DA; Desrosiers NA; Hartman RL; Pirard S; Huestis MA Drug Alcohol Depend; 2014 Nov; 144():12-41. PubMed ID: 25220897 [TBL] [Abstract][Full Text] [Related]
10. Gone to Pot - A Review of the Association between Cannabis and Psychosis. Radhakrishnan R; Wilkinson ST; D'Souza DC Front Psychiatry; 2014; 5():54. PubMed ID: 24904437 [TBL] [Abstract][Full Text] [Related]
11. Marijuana: current concepts(†). Greydanus DE; Hawver EK; Greydanus MM; Merrick J Front Public Health; 2013 Oct; 1():42. PubMed ID: 24350211 [TBL] [Abstract][Full Text] [Related]
12. Spicing things up: synthetic cannabinoids. Spaderna M; Addy PH; D'Souza DC Psychopharmacology (Berl); 2013 Aug; 228(4):525-40. PubMed ID: 23836028 [TBL] [Abstract][Full Text] [Related]
13. AKI associated with synthetic cannabinoids: a case series. Bhanushali GK; Jain G; Fatima H; Leisch LJ; Thornley-Brown D Clin J Am Soc Nephrol; 2013 Apr; 8(4):523-6. PubMed ID: 23243266 [TBL] [Abstract][Full Text] [Related]
14. Here today, gone tomorrow…and back again? A review of herbal marijuana alternatives (K2, Spice), synthetic cathinones (bath salts), kratom, Salvia divinorum, methoxetamine, and piperazines. Rosenbaum CD; Carreiro SP; Babu KM J Med Toxicol; 2012 Mar; 8(1):15-32. PubMed ID: 22271566 [TBL] [Abstract][Full Text] [Related]
15. Spice: a legal marijuana equivalent. Johnson LA; Johnson RL; Alfonzo C Mil Med; 2011 Jun; 176(6):718-20. PubMed ID: 21702397 [TBL] [Abstract][Full Text] [Related]
16. Spice: a new "legal" herbal mixture abused by young active duty military personnel. Bebarta VS; Ramirez S; Varney SM Subst Abus; 2012; 33(2):191-4. PubMed ID: 22489593 [TBL] [Abstract][Full Text] [Related]
17. From "herbal highs" to the "heroin of cannabis": Exploring the evolving discourse on synthetic cannabinoid use in a Norwegian Internet drug forum. Bilgrei OR Int J Drug Policy; 2016 Mar; 29():1-8. PubMed ID: 26860324 [TBL] [Abstract][Full Text] [Related]